Lee Nisley Newcomer - 02 Feb 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Lee Nisley Newcomer
Issuer symbol
CHRS
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 19:19:52 UTC
Previous filing
04 Jun 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +54,000 $0.000000 54,000 02 Feb 2022 Common Stock 54,000 $12.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 2, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.